Navigation Links
Lung Cancer Alliance Urges Inclusion of $5 Billion for Biomedical Research in Economic Stimulus Package
Date:1/29/2008

WASHINGTON, Jan. 29 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) urged leadership of the United States Senate to include funding for biomedical research in an economic stimulus package currently under consideration.

In letters hand carried to Capitol Hill, LCA Board Chairman Rear Admiral Phil Coady, USN (Ret.) and LCA President & CEO Laurie Fenton Ambrose pointed out that every family in America is paying an increasing proportion of income on health care costs -- a de facto tax increase that is falling disproportionately on low and middle income families.

"An injection of $5 billion in biomedical research with a mandate to prioritize funding based on disease mortality would provide an economic stimulus that would have far-reaching short and long-term benefits for the people of the United States and bolster our claim to world leadership on these issues," they stated.

They noted that the preeminence of US biomedical research is starting to slip, which will result in further job losses and disincentives for young people to pursue careers in innovation and technology.

LCA also called for benchmarks and accountability, proposing that research funding increases be allotted to diseases that continue to have high mortality rates.

The Senate Finance Committee is currently reviewing and revising the $150 billion economic stimulus package considered by the House of Representatives. The House package does not call for any increase in biomedical research.

Please visit http://www.lungcanceralliance.org to view the letter sent to the Senate Finance Committee.

Lung Cancer Alliance, http://www.lungcanceralliance.org, is the only national organization providing patient support and advocacy for those living with or at risk for lung cancer. LCA is committed to leading the movemen
'/>"/>

SOURCE Lung Cancer Alliance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Micromet Announces Public Offering of Common Stock 13262 1Micromet Announces Public Offering of Common Stock 13262 2Micromet Announces Public Offering of Common Stock 13262 3Micromet Announces Public Offering of Common Stock 13262 4Osteotech Resumes Shipments of Bulgarian Tissue 13259 1Osteotech Resumes Shipments of Bulgarian Tissue 13259 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 3PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5 2009 13256 1